Alembic Pharma posts net profit of Rs 719 crores for quarter ending March 31, 2016
Net sales was up by 54 per cent to Rs 3181 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
US retains India on priority watch list for IPR
It’s outrageous that the US government is once again attempting to stand in the way of India, says MSF
Commerce Secretary Rita Teaotia inaugurates 4th edition of iPHEX
Over 600 overseas business visitors, from over 100 countries, including regulators, senior health officials, media persons, NGO…
CII, IPO organise National Intellectual Property (IP) Awards: 2016
Recognises the use of IPRs as a strategic tool in commerce and industry
The Regional Centre for Biotechnology Bill, 2016 passed in Lok Sabha
The bill seeks to establish a regional centre for biotechnology, an institution of education, training and research, under UNESCO…
Syngene delivers sustained growth in Q4 FY16
Revenue grows 31 per cent to Rs 334 crore; EBITA up by 23 per cent to Rs 106 crore
OPPI with NLSU organises panel discussion to mark World IP Day
Discussions were held on how a good policy environment can reward innovation and protect intellectual property rights
ICMR, MoHFW, Govt. of Madhya Pradesh and Sun Pharma in agreement for Malaria Free India
Partnership to demonstrate malaria elimination in over 1,200 villages of MP's Mandla district by FY21
Govt committed to use TRIPS to protect domestic pharma: Nirmala Sitharaman
The reiteration came via a written reply in the Lok Sabha
Minister of State (Independent Charge) in the Ministry of Commerce…
Recalling stocks to re-label drugs with revised prices not mandatory: NPPA
NPPA's April 13 OM shifts onus of implementing revised prices to trade: DG Shah, IPA
Govt mulls setting up of CGMP facility for yellow fever drugs
According to the health minister, such a facility will help in supplying yellow fever vaccine to African and Latin American…
Alembic Pharma in JV agreement with Orbicular
To develop and commercialise dermatology products for global markets
Novartis’ Afinitor reduces seizures in patients with tuberous sclerosis complex
Results presented at American Academy of Neurology will be discussed with health authorities for potential worldwide regulatory…
India likely to impose anti-dumping duty on chemicals used by pharma industry
The duty will be imposed to protect the interests of domestic manufacturers
WHO suspends Anuh Pharma from pre-qualified list
The move comes in the wake of EQDM suspending certificate of suitability for the drug firm's three products last month
Aptar Pharma partners with Adapt Pharma
To provide delivery system and regulatory support for Narcan, a needle-free, ready-to use medication, which can stop or reverse…
IPM grew 6.4 per cent YoY to Rs 72 billion in March 2016: Motilal Oswal
Lupin, Sun Pharma and Mankind reports the highest growth in March 2016
IPA announces new office bearers
The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies…
Dr Harsh Vardhan inaugurates biotech infrastructure facility in Nagaland
It is a DBT funded facility which will conduct studies on Mithun, a semi-domesticated animal of bovine family
CII organises 13th National Pharma Conclave
The conclave with the theme 'Make, Develop and Innovate' addresses key issues of pharma sector